Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
2,916,735
-
Share change
-
+428,988
-
Total reported value
-
$62,341,000
-
Price per share
-
$21.37
-
Number of holders
-
15
-
Value change
-
+$9,168,044
-
Number of buys
-
9
-
Number of sells
-
4
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2018
As of 30 Sep 2018,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,916,735 shares.
The largest 10 holders included
Parametric Portfolio Associates LLC, GLENMEDE TRUST CO NA, Kepos Capital LP, FNY Investment Advisers, LLC, Pacer Advisors, Inc., NorthCoast Asset Management LLC, World Asset Management Inc, Pinnacle Wealth Planning Services, Inc., QUADRANT CAPITAL GROUP LLC, and Hexavest Inc..
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.